Burke & Herbert Bank & Trust’s Novartis NVS Stock Holding History

Burke & Herbert Bank & Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$603K	Sell	3,847 -97	-2%	-$14.5K	0.15%	135
2026 Q1	$602K	Hold	3,944	–	–	0.17%	123
2025 Q4	$544K	Buy	3,944 +290	+8%	+$38K	0.15%	131
2025 Q3	$469K	Hold	3,654	–	–	0.1%	161
2025 Q2	$442K	Hold	3,654	–	–	0.1%	162
2025 Q1	$407K	Hold	3,654	–	–	0.1%	169
2024 Q4	$356K	Hold	3,654	–	–	0.08%	177
2024 Q3	$420K	Hold	3,654	–	–	0.1%	169
2024 Q2	$389K	Buy	+3,654	New	+$367K	0.09%	169

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Burke & Herbert Bank & Trust's NVS Position: Q2 2026 in Review

Burke & Herbert Bank & Trust reduced its Novartis (NVS) stake by 2.5% in Q2 2026, selling an estimated $14.5K and leaving 3,847 shares worth $603K. The position accounts for 0.15% of the portfolio, ranked #135.

Burke & Herbert Bank & Trust first reported a position in NVS in Q2 2024 and has held it in 9 quarters since. 1,618 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Burke & Herbert Bank & Trust held 3,847 shares of Novartis worth $603K as of Q2 2026.
Burke & Herbert Bank & Trust sold 97 Novartis shares in Q2 2026, an estimated $14.5K.
Novartis made up 0.15% of Burke & Herbert Bank & Trust's portfolio in Q2 2026, its #135 holding.
Burke & Herbert Bank & Trust first reported a position in Novartis in Q2 2024 and has held it in 9 quarters since.
1,618 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Burke & Herbert Bank & Trust's 13F filing for Q2 2026, filed 7 Aug 2026.